A “National Poll of African-Americans on Sickle Cell Disease Awareness” conducted earlier this year has revealed that, while most African-Americans are…
Articles by Margarida Azevedo, MSc
The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to Altemia Soft Gelatin Capsules, developed…
Two pharmaceutical companies, Bioverativ and Bicycle Therapeutics, have agreed to jointly discover, develop and market novel therapies for sickle cell disease…
Sancilio Pharmaceuticals has completed enrolling patients in a Phase 2 clinical trial evaluating Altemia (docosahexaenoic acid) as a treatment for children…
The Israeli government has awarded Gamida Cell a $3.5 million grant to advance the development of clinical trials for CordIn, a…
Sema4, an interdisciplinary health information company, has partnered with Helix, a personal genomics company, to launch CarrierCheck — a…
Global Blood Therapeutics has expanded its ongoing HOPE-KIDS 1 trial (NCT02850406), evaluating the investigative GBT440 in pediatric patients…
The Health Resources and Services Administration (HRSA), part of the U.S. Department of Health and Human Services, has awarded the …
The Oncologic Drug Advisory Committee of the U.S. Food and Drug Administration (FDA) will review Emmaus Life Sciences’s New…
The inaugural World Cord Blood Day on Nov. 15 this year will educate parents and healthcare professionals about the current…